These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies. Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153 [TBL] [Abstract][Full Text] [Related]
9. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies? Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118 [TBL] [Abstract][Full Text] [Related]
10. FKBP12-immunopositive inclusions in patients with α-synucleinopathies. Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765 [TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease. Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916 [TBL] [Abstract][Full Text] [Related]
12. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy. Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358 [TBL] [Abstract][Full Text] [Related]
13. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells. Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256 [TBL] [Abstract][Full Text] [Related]
14. Sleep-controlling neurons are sensitive and vulnerable to multiple forms of α-synuclein: implications for the early appearance of sleeping disorders in α-synucleinopathies. Dos Santos AB; Skaanning LK; Thaneshwaran S; Mikkelsen E; Romero-Leguizamón CR; Skamris T; Kristensen MP; Langkilde AE; Kohlmeier KA Cell Mol Life Sci; 2022 Jul; 79(8):450. PubMed ID: 35882665 [TBL] [Abstract][Full Text] [Related]
15. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Koob AO; Ubhi K; Paulsson JF; Kelly J; Rockenstein E; Mante M; Adame A; Masliah E Exp Neurol; 2010 Feb; 221(2):267-74. PubMed ID: 19944097 [TBL] [Abstract][Full Text] [Related]
16. Neurons with Cat's Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions. De Giorgi F; Abdul-Shukkoor MB; Kashyrina M; Largitte LA; De Nuccio F; Kauffmann B; Lends A; Laferrière F; Bonhommeau S; Lofrumento DD; Bousset L; Bezard E; Buffeteau T; Loquet A; Ichas F Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327628 [TBL] [Abstract][Full Text] [Related]
17. A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo. Lopez A; Gorb A; Palha N; Fleming A; Rubinsztein DC Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627253 [TBL] [Abstract][Full Text] [Related]
18. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? Oueslati A J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784 [TBL] [Abstract][Full Text] [Related]
19. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies. Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613 [TBL] [Abstract][Full Text] [Related]
20. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels. Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]